Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
$10.33
$10.33
$8.57
$14.95
$22.52M2.0818,644 shsN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$3.12
+2.6%
$3.60
$2.90
$6.85
$64.45M0.78227,022 shs144,800 shs
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
0.00%0.00%0.00%0.00%-9.54%
PetMed Express, Inc. stock logo
PETS
PetMed Express
-1.94%-11.37%-15.56%-1.62%-24.75%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/AN/AN/AN/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
0.6662 of 5 stars
0.82.00.00.01.93.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
0.00
N/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.50
Reduce$3.357.37% Upside

Current Analyst Ratings Breakdown

Latest HFD, CURY, PETS, and MOON Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2025
PetMed Express, Inc. stock logo
PETS
PetMed Express
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$3.50 ➝ $3.20
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/AN/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$247.01M0.26$0.02 per share136.02$4.57 per share0.68
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/AN/A0.00N/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$7.46M$0.01312.31104.00N/A0.14%0.37%0.23%8/5/2025 (Estimated)

Latest HFD, CURY, PETS, and MOON Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q4 2025
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$0.02N/AN/AN/A$51.10 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/A1.92%N/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$0.9028.85%N/A9,000.00%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A
1.43
1.18

Institutional Ownership

CompanyInstitutional Ownership
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
73.33%

Insider Ownership

CompanyInsider Ownership
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Direxion Moonshot Innovators ETF MOON stock logo
MOON
Direxion Moonshot Innovators ETF MOON
N/A2.18 millionN/ANot Optionable
PetMed Express, Inc. stock logo
PETS
PetMed Express
21020.66 million20.43 millionOptionable

Recent News About These Companies

Head to Head Comparison: PetMed Express (PETS) versus Its Peers

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Direxion Moonshot Innovators ETF MOON stock logo

Direxion Moonshot Innovators ETF MOON NYSEARCA:MOON

$10.33 0.00 (0.00%)
As of 07/30/2024

The Direxion Moonshot Innovators ETF (MOON) is an exchange-traded fund that is based on the S&P Kensho Moonshots index. The fund tracks a tier-weighted index that selects US-listed companies seeking innovative technologies. MOON was launched on Nov 12, 2020 and is managed by Direxion.

PetMed Express stock logo

PetMed Express NASDAQ:PETS

$3.12 +0.08 (+2.63%)
Closing price 04:00 PM Eastern
Extended Trading
$3.20 +0.07 (+2.40%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.